6505--Request for Information (RFI) - Specialty – PPV 2028 Amendment 0002 to Extend Response Date from Nov. 16, 2026 to Nov. 30, 2026 at 11AM CT
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAC PRIME VENDOR (36W797)
Contract Value
Not provided
Codes & Classification
Solicitation Number
36E79727Q0001
NAICS
325412 - Pharmaceutical Preparation Manufacturing
Classification Code
6505
Additional Details
Documents4
The Department of Veterans Affairs (VA) has issued a Request for Information (RFI) under the title "Pharmaceutical Prime Vendor 2028 Specialty Pharmacy RFI," seeking input from industry stakeholders regarding its upcoming specialty pharmaceutical procurement initiative. This notice, identified by procurement number 36E79727Q0001, is a SOURCES SOUGHT announcement, indicating the VA's intent to gather information from potential vendors to inform future acquisition strategies for specialty pharmaceutical products and services.
The scope of this RFI centers on specialty pharmacy solutions, with the aim of supporting the VA's ongoing commitment to providing high-quality pharmaceutical care to veterans nationwide. The anticipated outcomes include identifying capable vendors, understanding market capabilities, and refining requirements for the eventual solicitation. The NAICS code associated with this procurement is 325412, which pertains to Pharmaceutical Preparation Manufacturing, underscoring the focus on manufacturers and suppliers of specialty pharmaceutical products.
This notice is managed by the NAC PRIME VENDOR office (entity code 36W797), a federal contracting entity within the Department of Veterans Affairs. The primary point of contact for this RFI is Karen Ade, who can be reached at [email protected] or via phone at 708-786-5231 for further inquiries or clarifications.
The current amendment (Amendment 0002) serves to extend the response deadline, allowing interested parties additional time to submit their information. The new response date is November 30, 2026, at 11:00 AM Central Time, superseding the previous deadline of November 16, 2026. All other aspects of the notice, including prior amendments, remain unchanged.
Contractors considering this opportunity should note that this is an information-gathering phase rather than a solicitation for bids or proposals. The VA is seeking input on specialty pharmacy capabilities, potential solutions, and industry best practices to inform the development of a future procurement. The Product Service Code is 6505, which relates to drugs and biologicals, further clarifying the nature of the required deliverables.
There are four attachments available on the SAM.gov posting, which may provide additional context or requirements. Interested parties are encouraged to review these materials and respond within the extended timeframe if their capabilities align with the VA's specialty pharmaceutical needs.
This RFI represents a significant opportunity for manufacturers and specialty pharmacy providers to engage with the VA and shape the requirements for a major upcoming procurement. The information collected will remain foundational throughout the contract lifecycle, ensuring that the VA's specialty pharmacy program is responsive to veteran needs and industry standards.
For further details and to access the full notice and attachments, visit the official SAM.gov opportunity page at: https://sam.gov/opp/63a3dfaad4a24ac7811daa48675edb1b/view.